# India Diagnostics Devices Market > India Diagnostics Devices Market Research Report Information By Type (Immunodiagnostics, Clinical Chemistry, Tissue Diagnostics, Haematology, Point of Care Tests, Molecular Diagnostics and Others), By Product Type (Instruments/Analysers and Reagents & Kits), By Application (Infectious Disease, Oncology, Hormone, Diabetes, Cardiac and Others), By End User (Diagnostic Chains, Individual Diagnostic Laboratories, Hospital Laboratories and Others) –Market Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 19.5% - **2024:** $ 2.99 Billion - **2025:** $ 3.57 Billion - **2035:** $ 21.21 Billion - **Key Players:** Siemens Healthineers (DE), Roche Diagnostics (CH), Abbott Laboratories (US), Thermo Fisher Scientific (US), Becton Dickinson and Company (US), Danaher Corporation (US), Sysmex Corporation (JP), Hologic, Inc. (US), Mylab Discovery Solutions (IN), Trivitron Healthcare (IN) **Report ID:** MRFR/MED/16247-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-diagnostics-devices-market-17775 --- ## Market Summary ## **India Diagnostics Devices Market Overview** As per MRFR analysis, the India Diagnostics Devices Market Size was estimated at 2.99 (USD Billion) in 2024. The India Diagnostics Devices Market Industry is expected to grow from 3.57 (USD Billion) in 2025 to 17.74 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 19.50% during the forecast period (2025 - 2034). Increasing prevalence of chronic diseases, growing awareness and focus on preventive healthcare, technological advancements, and increasing healthcare expenditure are the main market drivers anticipated to propel the diagnostics devices market in India. Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ## **Diagnostics Devices Market Trends** ### **Growing awareness and focus on preventive healthcare is driving the market growth** There is a growing awareness among the population about the importance of preventive healthcare. Individuals are increasingly opting for regular health check-ups and screenings to detect diseases at an early stage. This drives the demand for diagnostic devices for screening, monitoring, and early detection of diseases. There is a growing emphasis on healthy living and wellness, with individuals adopting healthier lifestyles, including regular exercise, balanced diets, and stress management. This increased health consciousness has led to a greater focus on preventive healthcare, including the use of diagnostic devices for health monitoring and early detection of potential health issues. Additionally, the growing awareness of preventive healthcare has led to an increase in the availability of screening and diagnostic services across healthcare facilities in India. Diagnostic centers, clinics, and hospitals are offering comprehensive health check-up packages and specialized screening programs to cater to the demand for preventive healthcare. This availability of services further encourages individuals to undergo regular screenings and diagnostic tests. Furthermore, the rising burden of chronic diseases such as diabetes, cardiovascular diseases, cancer, and respiratory disorders in India is driving the demand for diagnostic devices. Early and accurate diagnosis is crucial for effective disease management, leading to increased adoption of diagnostic devices. In addition, the Indian government and healthcare organizations have been actively promoting preventive healthcare through various initiatives and awareness campaigns. Programs such as National Health Mission (NHM), Ayushman Bharat, and National Non-Communicable Disease Control Program (NPCDCS) aim to raise awareness about the importance of preventive measures, including regular screenings and diagnostic tests. These initiatives contribute to increased awareness and drive the adoption of diagnostic devices. ## **Diagnostics Devices Market Segment Insights** ### **Diagnostics Devices Type Insights** India Diagnostics Devices market segmentation, based on type includes Immunodiagnostics, Clinical Chemistry, Tissue Diagnostics, Haematology, Point of Care Tests, Molecular Diagnostics and Others. The immunodiagnostics segment dominated the market mostly. Immunodiagnostics involves the detection and measurement of specific antigens or antibodies in the body to diagnose and monitor various diseases, including infectious diseases, autoimmune disorders, and cancer. Immunodiagnostics is widely used for screening, diagnosis, and monitoring of diseases, contributing to its high demand in the Indian market. ### **Diagnostics Devices Product Type Insights** India Diagnostics Devices market segmentation, based on product type, includes Instruments/Analysers and Reagents & Kits. The instruments/analyzers category generated the most income. Diagnostic instruments/analyzers are essential tools used for the analysis and interpretation of diagnostic tests. They play a crucial role in the accurate and efficient diagnosis of various diseases and conditions. These instruments are used in hospitals, diagnostic centers, and laboratories, contributing to their high demand in the market. ### **Diagnostics Devices Application Insights** India Diagnostics Devices market segmentation, based on application includes Infectious Disease, Oncology, Hormone, [Diabetes](../../../reports/diabetes-drug-market-1160), Cardiac and Others. The infectious disease segment dominated the market mostly. Infectious diseases, including viral, bacterial, and parasitic infections, pose a significant healthcare burden in India. Diseases such as tuberculosis, malaria, dengue, hepatitis, and HIV/AIDS are prevalent in the country. The need for accurate and timely diagnosis of infectious diseases drives the demand for diagnostic devices in this segment. ### **Diagnostics Devices End User Insights** India Diagnostics Devices market segmentation, based on end user includes Diagnostic Chains, Individual Diagnostic Laboratories, Hospital Laboratories and Others. The hospital laboratories segment dominated the market mostly. Hospital laboratories typically handle a large volume of diagnostic tests due to the wide range of medical services provided in hospitals. These laboratories cater to the diagnostic needs of inpatients, outpatients, and emergency cases. The high volume of tests performed in hospital laboratories contributes to their dominance in the market. **Figure 1: India Diagnostics Devices Market, by End User, 2022 & 2032 (USD Billion)** Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ### **Diagnostics Devices Country Insights** India is a rapidly growing market for diagnostics devices, driven by factors such as increasing healthcare expenditure, growing awareness about preventive healthcare, rising incidence of chronic diseases, and government initiatives to improve healthcare infrastructure. The Indian government has implemented several initiatives to improve healthcare infrastructure and access to diagnostic services. Initiatives such as Ayushman Bharat, National Health Mission (NHM), and National Non-Communicable Disease Control Program (NPCDCS) focus on preventive healthcare, early detection, and treatment of diseases, thereby driving the demand for diagnostic devices. Moreover, the private sector plays a crucial role in the India Diagnostics Devices Market, with private diagnostic chains and laboratories offering a wide range of diagnostic tests and services. These private players contribute significantly to the market growth, especially in urban areas. Also, the market is witnessing rapid technological advancements in diagnostic devices, including the integration of artificial intelligence (AI), automation, and digital health technologies. These advancements enhance the accuracy, efficiency, and accessibility of diagnostic tests, driving market growth. ## **Diagnostics Devices Key Market Players & Competitive Insights** Leading market players are investing heavily in research and development in order to expand their product lines, which will help the diagnostics devices market grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the diagnostics devices industry must offer cost-effective items. Major players in the diagnostics devices market are attempting to increase market demand by investing in research and development operations includes Roche Diagnostics India Private Limited; Siemens Ltd. (Siemens Healthineers India); Becton Dickinson India Pvt Ltd; Beckman Coulter India Private Limited; Abbott India; Transasia Bio-Medicals Limited; Tulip Diagnostics Pvt Ltd; Trivitron Healthcare Pvt Ltd. ### **Key Companies in the diagnostics devices market include** - Roche Diagnostics India Private Limited - Siemens Ltd. (Siemens Healthineers India) - Becton Dickinson India Pvt Ltd - Beckman Coulter India Private Limited - Abbott India - Transasia Bio-Medicals Limited - Tulip Diagnostics Pvt Ltd - [Trivitron Healthcare Pvt Ltd.](https://www.trivitron.com/news/trivitron-healthcare-unveils-indias-first-fully-automatic-radiation-protection-gloves-manufacturing-facility-at-amtz-visakhapatnam) ### **Diagnostics Devices Industry Developments** **September 2021:**Abbott launched its Alinity m Resp-4-Plex molecular diagnostic test, which can detect and differentiate between SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) in a single test. **July 2021:**Bio-Rad Laboratories launched its QXDx AutoDG ddPCR System, a fully automated droplet digital PCR (ddPCR) system for high-throughput research and clinical laboratories. ## **Diagnostics Devices Market Segmentation** ### **Diagnostics Devices Type Outlook** - Immunodiagnostics - Clinical Chemistry - Tissue Diagnostics - Haematology - Point of Care Tests - Molecular Diagnostics - Others ### **Diagnostics Devices Product Type Outlook** - Instruments/Analysers - Reagents & Kits ### **Diagnostics Devices Application Outlook** - Infectious Disease - Oncology - Hormone - Diabetes - Cardiac - Others ### **Diagnostics Devices End User Outlook** - Diagnostic Chains - Individual Diagnostic Laboratories - Hospital Laboratories - Others ### **Diagnostics Devices Type Outlook** ## Market Drivers ### Rising Prevalence of Chronic Diseases The increasing incidence of chronic diseases in India is a pivotal driver for the India Diagnostics Devices Market. As lifestyle-related ailments such as diabetes, cardiovascular diseases, and respiratory disorders become more prevalent, the demand for diagnostic devices is expected to surge. According to recent estimates, chronic diseases account for approximately 60% of all deaths in India, necessitating advanced diagnostic solutions. This trend compels healthcare providers to invest in innovative diagnostic technologies, thereby propelling market growth. The India Diagnostics Devices Market is likely to witness a robust expansion as healthcare systems adapt to the growing need for early detection and management of these conditions. ### Government Initiatives and Investments Government initiatives aimed at enhancing healthcare infrastructure significantly influence the India Diagnostics Devices Market. The Indian government has launched various programs to improve healthcare access and affordability, including the Ayushman Bharat scheme, which aims to provide health insurance to millions. Such initiatives are likely to stimulate investments in diagnostic technologies, as healthcare facilities upgrade their capabilities to meet the increased demand. Furthermore, the government's focus on promoting indigenous manufacturing of diagnostic devices could lead to a more competitive market landscape. This strategic direction may enhance the overall growth trajectory of the India Diagnostics Devices Market, fostering innovation and accessibility. ### Growing Demand for Point-of-Care Testing The shift towards point-of-care testing (POCT) is transforming the India Diagnostics Devices Market. POCT offers rapid results and convenience, making it increasingly popular among healthcare providers and patients alike. The market for POCT devices is projected to grow at a compound annual growth rate (CAGR) of over 10% in the coming years, driven by the need for timely diagnosis and treatment. This trend is particularly relevant in rural and underserved areas, where access to traditional laboratory facilities may be limited. As healthcare systems prioritize efficiency and patient-centric care, the India Diagnostics Devices Market is likely to expand in response to this growing demand for POCT solutions. ### Technological Innovations in Diagnostic Devices Technological advancements play a crucial role in shaping the India Diagnostics Devices Market. Innovations such as artificial intelligence, machine learning, and advanced imaging techniques are enhancing the accuracy and efficiency of diagnostic devices. These technologies enable healthcare professionals to make more informed decisions, ultimately improving patient outcomes. The integration of digital health solutions, including telemedicine and remote monitoring, is also gaining traction, further driving the demand for sophisticated diagnostic tools. As the market evolves, the continuous introduction of cutting-edge technologies is expected to propel the growth of the India Diagnostics Devices Market, fostering a more effective healthcare ecosystem. ### Increasing Health Awareness and Preventive Healthcare The rising health consciousness among the Indian population is a significant driver for the India Diagnostics Devices Market. As individuals become more aware of the importance of regular health check-ups and preventive measures, the demand for diagnostic devices is likely to increase. Public health campaigns and educational initiatives are encouraging people to seek early diagnosis and treatment, thereby fostering a culture of preventive healthcare. This shift in mindset is expected to lead to a higher utilization of diagnostic services, which in turn could stimulate growth in the market. The India Diagnostics Devices Market stands to benefit from this trend as healthcare providers adapt to meet the evolving needs of a more health-conscious society. ## Future Outlook The India Diagnostics Devices Market is projected to grow at a 19.5% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare expenditure, and rising demand for early disease detection. **New opportunities:** - Expansion of [telemedicine](https://www.marketresearchfuture.com/reports/telemedicine-market-2216)-integrated diagnostic platforms Development of portable diagnostic devices for rural healthcare Investment in AI-driven diagnostic analytics solutions By 2035, the market is expected to be robust, reflecting substantial growth and innovation. ## Segment Insights ### By Type: Immunodiagnostics (Largest) vs. Molecular Diagnostics (Fastest-Growing) In the India Diagnostics Devices Market, segment distribution shows Immunodiagnostics holding a significant share, cementing its position as the largest segment. Clinical Chemistry and Haematology follow closely, catering to essential diagnostic requirements across hospitals and laboratories. Tissue Diagnostics and Point of Care Tests are also crucial, but their shares are comparatively smaller, indicating a more niche role within the broader diagnostics landscape. The Others category captures various emerging technologies, though it contributes less to the overall market share compared to the primary segments. Immunodiagnostics (Dominant) vs. Molecular Diagnostics (Emerging) Immunodiagnostics stands out as the dominant segment in the India Diagnostics Devices Market, characterized by its extensive application in infectious disease testing, autoimmune disorders, and allergies. Its established technologies and methods contribute to a consistent demand from healthcare providers. Meanwhile, Molecular Diagnostics is emerging rapidly, driven by advancements in genetic testing and personalized medicine. The growth is fueled by increasing awareness of genetic disorders and infectious diseases, leading to a rising acceptance of molecular techniques in routine diagnostics. Both segments exhibit unique advantages, with Immunodiagnostics providing reliability and Molecular Diagnostics pushing the boundaries of diagnostic precision. ### By Product Type: Instruments/Analysers (Largest) vs. Reagents & Kits (Fastest-Growing) In the India Diagnostics Devices Market, the market share distribution indicates that Instruments/Analysers hold the largest share, reflecting their essential role in diagnostic processes. This segment's dominance is attributed to the increasing prevalence of chronic diseases, driving the need for advanced diagnostic equipment across healthcare settings. In contrast, Reagents & Kits are rapidly gaining traction, appealing particularly to laboratories and healthcare providers seeking efficient and effective testing solutions. This division’s market share is bolstered by innovations in reagent technologies and the demand for rapid test kits during health emergencies. Product Type: Instruments/Analysers (Dominant) vs. Reagents & Kits (Emerging) Instruments/Analysers are recognized as the dominant force within the India Diagnostics Devices Market, playing a crucial role in providing accurate and timely results across various clinical settings. These devices include a broad range of technologies such as analyzers, imaging devices, and point-of-care instruments that cater to diverse diagnostic needs. On the other hand, Reagents & Kits are emerging as a rapidly developing segment, with their ease of use and quick turnaround times driving their growth. The increasing focus on point-of-care testing and personalized medicine is propelling demand for these products, making them essential components within the diagnostic ecosystem and appealing to both healthcare professionals and patients. ### By Application: Infectious Disease (Largest) vs. Diabetes (Fastest-Growing) In the India Diagnostics Devices Market, the application segment is largely driven by the infectious disease diagnostics, which holds the largest market share. This dominance can be attributed to the heightened focus on disease outbreak management and the rising prevalence of [infectious diseases](https://www.marketresearchfuture.com/reports/infectious-disease-treatments-market-1626) in the region. Other applications, such as oncology and cardiac diagnostics, also play a significant role, but they remain secondary when compared to the infectious disease sector, emphasizing the critical need for advanced diagnostic solutions. In contrast, the diabetes diagnostic market is recognized as the fastest-growing segment. This growth is fueled by increasing diabetes prevalence, changes in lifestyle, and heightened awareness regarding early detection. As more consumers seek effective and timely diabetes management solutions, this segment's innovations in technology and accessibility are key to meeting growing demands, indicating a substantial transformation in the diagnostics landscape. Infectious Disease (Dominant) vs. Diabetes (Emerging) The infectious disease diagnostics segment remains dominant in the India Diagnostics Devices Market, characterized by robust technological advancements and substantial investments in disease detection methodologies. This segment encompasses a range of testing devices, specifically tailored to identify pathogens effectively and efficiently. With the rising incidences of infectious diseases, healthcare providers are increasingly adopting comprehensive diagnostic solutions. On the other hand, the diabetes diagnostics sector is emerging rapidly, driven by alarming diabetes statistics nationwide. This segment has seen intensified focus on developing user-friendly devices that facilitate self-monitoring and timely intervention. Both segments exhibit unique market characteristics, with infectious disease diagnostics leading in established practices while diabetes diagnostics captures attention due to its transformative potential. ### By End User: Diagnostic Chains (Largest) vs. Hospital Laboratories (Fastest-Growing) In the India Diagnostics Devices Market, the end-user segment showcases a diverse range of players, with Diagnostic Chains holding a significant share. They have established a robust presence across urban areas, catering to a large volume of diagnostic tests daily. Individual Diagnostic Laboratories and Hospital Laboratories follow, with Individual Laboratories focusing on localized services while Hospital Laboratories integrate diagnostics into patient care. Moreover, the segment of Others, which includes mobile and point-of-care testing facilities, is gaining traction, complementing traditional testing methods. Diagnostic Chains (Dominant) vs. Hospital Laboratories (Emerging) Diagnostic Chains are characterized by their extensive network and scale, which enable them to leverage economies of scale and deliver a broad spectrum of services. They are increasingly adopting advanced technologies to enhance service delivery, fostering patient trust and convenience. In contrast, Hospital Laboratories are emerging as vital players in the diagnostics field, integrating diagnostic services with clinical procedures to expedite patient diagnosis and treatment. Their collaboration with healthcare providers enhances operational efficiency, leading to improved patient outcomes and fostering a growing trend towards in-house diagnostic capabilities. ## Competitive Benchmarking The India Diagnostics Devices Market is currently characterized by a dynamic competitive landscape, driven by technological advancements, increasing healthcare demands, and a growing emphasis on early disease detection. Major players such as Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), and Abbott Laboratories (United States) are strategically positioned to leverage innovation and regional expansion. Siemens Healthineers (Germany) focuses on enhancing its imaging and laboratory diagnostics capabilities, while Roche Diagnostics (Switzerland) emphasizes personalized healthcare solutions. Abbott Laboratories (United States) is actively pursuing partnerships to expand its diagnostic portfolio, thereby shaping a competitive environment that prioritizes technological integration and patient-centric solutions.Key business tactics within the market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The competitive structure appears moderately fragmented, with a mix of multinational corporations and local players like Mylab Discovery Solutions (India) and Trivitron Healthcare (India) contributing to the market dynamics. These local entities often capitalize on their understanding of regional healthcare needs, which complements the broader strategies of international firms, creating a multifaceted competitive landscape. In August Roche Diagnostics (Switzerland) announced the launch of a new point-of-care testing device aimed at improving rapid diagnostics in rural areas. This strategic move is significant as it aligns with the increasing demand for accessible healthcare solutions in underserved regions, potentially enhancing Roche's market share and reinforcing its commitment to innovation in diagnostics. In September Abbott Laboratories (United States) expanded its collaboration with local healthcare providers to enhance the distribution of its diagnostic products across India. This initiative is likely to strengthen Abbott's presence in the market, allowing for better penetration and responsiveness to local healthcare demands, which is crucial in a diverse and populous country like India. In October Siemens Healthineers (Germany) unveiled a new digital platform designed to integrate artificial intelligence into diagnostic workflows. This development is indicative of a broader trend towards digitalization in the diagnostics sector, suggesting that Siemens is positioning itself at the forefront of technological innovation, which may enhance operational efficiencies and improve patient outcomes. As of October current competitive trends in the India Diagnostics Devices Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing supply chain reliability. Looking ahead, it appears that competitive differentiation will likely evolve from traditional price-based competition to a focus on technological advancements and innovative solutions, underscoring the importance of adaptability in a rapidly changing market. ## Recent News & Developments **September 2021:**Abbott launched its Alinity m Resp-4-Plex molecular diagnostic test, which can detect and differentiate between SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) in a single test. **July 2021:**Bio-Rad Laboratories launched its QXDx AutoDG ddPCR System, a fully automated droplet digital PCR (ddPCR) system for high-throughput research and clinical laboratories. ## Report Scope | MARKET SIZE 2024 | 2.988(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 3.57(USD Billion) | | MARKET SIZE 2035 | 21.21(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 19.5% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Siemens Healthineers (DE), Roche Diagnostics (CH), Abbott Laboratories (US), Thermo Fisher Scientific (US), Becton Dickinson and Company (US), Danaher Corporation (US), Sysmex Corporation (JP), Hologic, Inc. (US), Mylab Discovery Solutions (IN), Trivitron Healthcare (IN) | | Segments Covered | Type, Product Type, Application, End User | | Key Market Opportunities | Integration of artificial intelligence in diagnostic devices enhances accuracy and efficiency in the India Diagnostics Devices Market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the India Diagnostics Devices Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the India Diagnostics Devices Market in 2024?** A: The market valuation of the India Diagnostics Devices Market was 2.988 USD Billion in 2024. **Q: What is the projected market size for the India Diagnostics Devices Market by 2035?** A: The projected market size for the India Diagnostics Devices Market is expected to reach 21.21 USD Billion by 2035. **Q: What is the expected CAGR for the India Diagnostics Devices Market during the forecast period 2025 - 2035?** A: The expected CAGR for the India Diagnostics Devices Market during the forecast period 2025 - 2035 is 19.5%. **Q: Which segment is projected to have the highest valuation in the India Diagnostics Devices Market by 2035?** A: The Reagents & Kits segment is projected to reach a valuation of 12.65 USD Billion by 2035. **Q: What are the key applications driving growth in the India Diagnostics Devices Market?** A: Key applications include Diabetes, Oncology, and Infectious Disease, with projected valuations of 4.5 USD Billion, 4.2 USD Billion, and 3.5 USD Billion respectively by 2035. **Q: Who are the leading players in the India Diagnostics Devices Market?** A: Leading players in the market include Siemens Healthineers, Roche Diagnostics, and Abbott Laboratories, among others. **Q: What is the projected valuation for the Point of Care Tests segment by 2035?** A: The Point of Care Tests segment is projected to reach a valuation of 3.0 USD Billion by 2035. **Q: How does the market for Hospital Laboratories compare to Individual Diagnostic Laboratories in 2035?** A: By 2035, the market for Hospital Laboratories is projected to be valued at 8.1 USD Billion, compared to 3.8 USD Billion for Individual Diagnostic Laboratories. **Q: What is the expected growth trend for the Immunodiagnostics segment in the coming years?** A: The Immunodiagnostics segment is expected to grow to 3.5 USD Billion by 2035, indicating a robust growth trajectory. **Q: What role do local companies play in the India Diagnostics Devices Market?** A: Local companies like Mylab Discovery Solutions and Trivitron Healthcare are contributing to market growth, enhancing competition and innovation. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-diagnostics-devices-market-17775*